Vitamin C, Hydrocortisone and Thiamine for Septic Shock (CORVICTES)
A Randomized, Double Blind, Placebo-Controlled Trial to Investigate the Effect of Vitamin C, Hydrocortisone and Thiamine on the Outcome of Patients with Septic Shock
Sponsor: General Hospital of Nikaia Saint Panteleimon
Terminated
Low rate of enrollment; publication of relevant results by other groups
Other Shock, Septic trials with similar outcome
A PHASE2 clinical study on Shock, Septic, this trial is terminated or withdrawn. The trial is conducted by General Hospital of Nikaia Saint Panteleimon and has accumulated 12 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
12 versions recorded-
Jan 2025 — Present [monthly]
Terminated PHASE2
Status: Recruiting → Terminated
-
Sep 2024 — Jan 2025 [monthly]
Recruiting PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE2
-
Jun 2023 — Jul 2024 [monthly]
Recruiting PHASE2
-
Feb 2022 — Jun 2023 [monthly]
Recruiting PHASE2
▶ Show 7 earlier versions
-
Jan 2021 — Feb 2022 [monthly]
Recruiting PHASE2
-
Dec 2020 — Jan 2021 [monthly]
Recruiting PHASE2
-
Sep 2020 — Dec 2020 [monthly]
Recruiting PHASE2
-
Oct 2019 — Sep 2020 [monthly]
Recruiting PHASE2
-
Oct 2018 — Oct 2019 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Sep 2018 — Oct 2018 [monthly]
Not Yet Recruiting PHASE2
-
Aug 2018 — Sep 2018 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- General Hospital of Nikaia Saint Panteleimon
- Naval Hospital, Athens
- University of Athens
For direct contact, visit the study record on ClinicalTrials.gov .